← Leaderboards
Peter Kabos
University Of Colorado Denver
$4,181,941
Attributed
$6,563,122
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,563,122 · 4
By mechanism
R01$5,704,522 · 3
K08$858,600 · 1
Top collaborators
- Victoria A Catenacci4 shared
- Paul S Maclean4 shared
- Carol Ann Sartorius4 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Igor Kogut$2,346,523
- Paula C Bickford$5,784,723
- Elizabeth Wellberg$1,612,619
- Victoria A Catenacci$13,159,123
- Paul Jedlicka$2,496,302
Others in their field
Top investigators on “Estrogen Receptor Positive”
- David Heimbrook · Leidos Biomedical Research, Inc.$29,594,272
- Norman Wolmark · Nsabp Foundation, Inc.$27,593,122
- Susan E. Hankinson · University Of Massachusetts Amherst$18,127,754
- Matthew J Ellis · Duke University$12,740,907
- Donald P McDonnell · Duke University$10,223,799
- Marlene Rabinovitch · Stanford University$8,849,330
Research focus
Estrogen Receptor PositiveEstrogensMalignant NeoplasmsEstrogen ReceptorsBreast Cancer CellHormone TherapyRegulationMalignant Breast NeoplasmMemberTumorCellsLinkBreast Cancer Cell LineBaseGene ExpressionBiologicalGene Expression RegulationFeedbackFamilyFibroblastsGenesEndocrineColoradoCessation Of Life
Grant awards (18)
Novel dietary interventions for reducing obesity-associated breast cancer$641,100
R01 · FY2025 · CA
Hormone Receptor Regulation of RNA Polymerase III$364,893
R01 · FY2025 · GM
Novel dietary interventions for reducing obesity-associated breast cancer$612,513
R01 · FY2024 · CA
Hormone Receptor Regulation of RNA Polymerase III$364,893
R01 · FY2024 · GM
Novel dietary interventions for reducing obesity-associated breast cancer$616,579
R01 · FY2023 · CA
Hormone Receptor Regulation of RNA Polymerase III$364,893
R01 · FY2023 · GM
Novel dietary interventions for reducing obesity-associated breast cancer$606,900
R01 · FY2022 · CA
Hormone Receptor Regulation of RNA Polymerase III$364,893
R01 · FY2022 · GM
Cancer-associated fibroblasts in estrogen receptor positive breast cancer.$355,706
R01 · FY2020 · CA · contact PI
Cancer-associated fibroblasts in estrogen receptor positive breast cancer.$345,034
R01 · FY2019 · CA · contact PI
Cancer-associated fibroblasts in estrogen receptor positive breast cancer.$355,706
R01 · FY2018 · CA · contact PI
Cancer-associated fibroblasts in estrogen receptor positive breast cancer.$355,706
R01 · FY2017 · CA · contact PI
Cancer-associated fibroblasts in estrogen receptor positive breast cancer.$355,706
R01 · FY2016 · CA · contact PI
Regulation of anti-endocrine resistance of breast cancer by a network of non-codi$171,720
K08 · FY2016 · CA · contact PI
Regulation of anti-endocrine resistance of breast cancer by a network of non-codi$171,720
K08 · FY2015 · CA · contact PI
Regulation of anti-endocrine resistance of breast cancer by a network of non-codi$171,720
K08 · FY2014 · CA · contact PI
Regulation of anti-endocrine resistance of breast cancer by a network of non-codi$171,720
K08 · FY2013 · CA · contact PI
Regulation of anti-endocrine resistance of breast cancer by a network of non-codi$171,720
K08 · FY2012 · CA · contact PI